Security key
746964105
CUSIP: 746964105
Security key
746964105
Report period
Q3 2025
Institutions
52
Top holders
10
Broader feeds
Reporting periods
Recent filing periods:
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Rank 1 holder
Rank 2 holder
Rank 3 holder
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PFIZER INC |
13D/G
13F
Pfizer Inc. (IRS Identification No.: 13-5315170) · Company
|
2.3%
|
$994,442
277,777 shares
|
$0 | 31 Dec 2024 |
| BRISTOL MYERS SQUIBB CO |
13D/G
|
1.6%
|
$312,381
200,244 shares
|
$0 | 31 Dec 2024 |
| ORBIMED ADVISORS LLC |
13F
3/4/5
Company · Director, 10%+ Owner
|
9.4%
|
$3,356,951
2,252,987 shares
|
— | 30 Jun 2025 |
| Atlas Venture Life Science Advisors, LLC |
13F
Company
|
8.7%
|
$3,117,238
2,092,106 shares
|
— | 30 Jun 2025 |
| Carlyle Group Inc. |
13F
Company
|
4.6%
|
$1,621,029
1,102,741 shares
|
— | 30 Jun 2025 |
| ACORN CAPITAL ADVISORS, LLC |
13F
Company
|
3.3%
|
$1,197,103
803,425 shares
|
— | 30 Jun 2025 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Investor-level positions for this CUSIP, loaded as an interactive table.
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).